ZIOPHARM ONCOLOGY INC 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jun 5, 2015
Insider Transaction Report
Form 4
Lafond Kevin G
Vice Pres., Treasurer, & CAO
Transactions
- Exercise/Conversion
Common Stock
2015-06-03$2.30/sh+27,500$63,250→ 27,500 total - Exercise/Conversion
Stock Option (right to buy)
2015-06-03−27,500→ 55,000 totalExercise: $2.30Exp: 2023-06-27→ Common Stock (27,500 underlying) - Sale
Common Stock
2015-06-03$9.60/sh−26,666$255,994→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2015-06-03−3,334→ 0 totalExercise: $0.80Exp: 2019-02-06→ Common Stock (3,334 underlying) - Exercise/Conversion
Common Stock
2015-06-03$0.80/sh+3,334$2,667→ 3,334 total - Sale
Common Stock
2015-06-03$9.70/sh−3,334$32,340→ 0 total - Sale
Common Stock
2015-06-03$9.70/sh−27,500$266,750→ 0 total
Footnotes (2)
- [F1]Fully vested.
- [F2]27,500 shares vest on each of 6/27/2014, 6/27/2015 and 6/27/2016.